CONOCOPHILLIPS reported revenue of $19.16B for the period ended 2026-06-30, +36.8% year on year. Net income was $3.93B, a 20.5% net margin on a 100.0% gross margin. Free cash flow for the period was $4.41B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | $19.16B | +36.8% |
| Gross profit | $19.16B | — |
| Operating income | $6.08B | — |
| Net income | $3.93B | +99.4% |
| Gross margin | 100.0% | Net margin 20.5% |
| Revenue Q/Q | +21.6% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| SG&A | $0.19B | 1.0% |
| Tax & other | $2.15B | 11.2% |
| Item | Amount |
|---|---|
| Total assets | $124.26B |
| Total liabilities | $58.91B |
| Shareholders' equity | $65.35B |
| Equity / assets | 52.6% |
| Operating cash flow | $7.43B |
| Capital expenditure | $3.02B |
| Free cash flow | $4.41B |
| Cash conversion (OCF / net income) | 189% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
ED ・ STZ ・ CEG ・ COO ・ CPRT ・ GLW ・ CPAY ・ CTVA ・ CSGP ・ COST ・ CRH ・ CRWD
Source: SEC EDGAR · This page shows public filing data only, not investment advice. · Browse all companies